Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07482644 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of an Essential Oil-Based Product System for Immune Support
A NA study, sponsored by dōTERRA International.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07482644: Recruiting NA study, sponsored by dōTERRA International.
NCT07482644 is a NA study that is actively recruiting participants, run by dōTERRA International. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07482644, a NA study, is actively recruiting participants, sponsored by dōTERRA International.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This randomized, double-blind, placebo-controlled clinical trial will evaluate the safety and efficacy of an essential oil-based product system for immune support in healthy adolescents and adults aged 18-45 years. Participants will be randomized to receive aromatic, topical, internal, or combined use of the investigational product or matching placebo for 30 days. The aromatic intervention consists of overnight diffusion, the topical intervention consists of diluted application to specified areas prior to bedtime, and the internal intervention consists of oral capsule administration twice daily. Study visits will occur at baseline and at the end of the 30-day intervention period. Primary outcomes include changes in immune-related biomarkers, including complete blood count, comprehensive metabolic panel, salivary immunoglobulin A (IgA), and inflammatory cytokines (IL-6, TNF-α, IL-10). Epigenetic markers will also be evaluated. Secondary outcomes include validated subjective assessments of immune status and overall well-being, as well as evaluation of safety and tolerability. The study includes an adaptive design with interim analysis to assess enrollment and study continuation parameters.
Interventions
- DRUG Placebo
- DRUG Essential Oil Blend (Botanical Combination Product)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-06-10 |
| Est. Completion | 2026-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07482644
The ClinicalTrials.gov registry entry for NCT07482644 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is dōTERRA International, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07482644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07482644 about?
NCT07482644 is a clinical study titled "Efficacy and Safety of an Essential Oil-Based Product System for Immune Support". This randomized, double-blind, placebo-controlled clinical trial will evaluate the safety and efficacy of an essential oil-based product system for immune support in healthy adolescents and adults aged 18-45 years. Participants will be randomized to receive aromatic, topical, internal, or combined u...
What is the current status of trial NCT07482644?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-06-10. Estimated completion is 2026-09-17.
What interventions are being tested in trial NCT07482644?
The interventions under investigation include: Placebo (DRUG), Essential Oil Blend (Botanical Combination Product) (DRUG).
Who is sponsoring clinical trial NCT07482644?
This trial is sponsored by dōTERRA International, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.